Disaster Recovery: Six Things Labs Can Do

October, 2012 By Douglas Beigel, Chief Executive Officer COLA In October, during the week of lab-related events COLA hosted in Baltimore, we heard a number of inspirational stories related to lab medicine and the impact it has on patient safety. But during a week of great stories, one story stood out from among the rest.…

COLA Shares Important Information about the Meningitis Outbreak

The CDC has released the following diagnostic testing instructions for the Multistate Fungal Meningitis Outbreak Investigation. If you have any other questions please contact COLA directly at 1-800-981-9883. Diagnostic Testing for Septic Arthritis and Specimen Submission to CDC – Outbreak Associated with Injection of Potentially Contaminated Steroid Products The pathogens involved in this cluster of…

Credit: Architect of the Capitol

Legislation addressing PT Referral Controversy Moves in Congress

Legislation to resolve a longstanding issue with respect to CLIA enforcement – specifically, how federal regulators handle labs that mistakenly refer proficiency test samples(PT) to other labs – has moved forward in both houses of Congress. On September 20, H.R. 6118, the Taking Essential Steps for Testing Act (TEST Act), introduced by Rep. Michael Grimm…

A Celebration of Laboratory Medicine

By Douglas Beigel, CEO, COLA September, 2012 With the presidential election only weeks away, the healthcare debate will only continue to intensify as it relates to federal healthcare reform, proposed changes to Medicare, budget “sequestration,” and other health-related spending cuts. It’s a good time for all of us to shine a light on the critical…